↓ Skip to main content

Glutamatergic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
1 blog
twitter
6 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
84 Mendeley
citeulike
5 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glutamatergic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, April 2006
DOI 10.1002/14651858.cd003730.pub2
Pubmed ID
Authors

Jari Tiihonen, Kristian Wahlbeck

Abstract

It has been shown that central nervous system dopamine can play a major role in the pathophysiology of schizophrenia. Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in the brain. It might be possible to decrease negative symptoms and the cognitive impairment of people with schizophrenia by treatment with glutamatergic drugs.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
Canada 3 4%
United Kingdom 2 2%
Brazil 1 1%
Unknown 75 89%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 17%
Professor > Associate Professor 10 12%
Student > Bachelor 10 12%
Researcher 9 11%
Student > Master 9 11%
Other 24 29%
Unknown 8 10%
Readers by discipline Count As %
Medicine and Dentistry 33 39%
Psychology 9 11%
Agricultural and Biological Sciences 9 11%
Neuroscience 7 8%
Nursing and Health Professions 5 6%
Other 9 11%
Unknown 12 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2019.
All research outputs
#1,338,871
of 14,532,993 outputs
Outputs from Cochrane database of systematic reviews
#3,756
of 10,988 outputs
Outputs of similar age
#15,614
of 153,307 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 121 outputs
Altmetric has tracked 14,532,993 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,988 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 153,307 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.